126 related articles for article (PubMed ID: 11697325)
1. Enhanced apoptosis and radiosensitization by combined 13-cis-retinoic acid and interferon-alpha2a; role of RAR-beta gene.
Ryu S; Stein JP; Chung CT; Lee YJ; Kim JH
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):785-90. PubMed ID: 11697325
[TBL] [Abstract][Full Text] [Related]
2. In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a.
Ryu S; Kim OB; Kim SH; He SQ; Kim JH
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):869-73. PubMed ID: 9652851
[TBL] [Abstract][Full Text] [Related]
3. Effects of retinoic acid and interferon-gamma on expression of the retinoic acid receptor in mouse renal cell carcinoma.
Hara I; Taguchi I; Miyake H; Hara S; Gotoh A; Kamidono S
Int J Oncol; 2001 Nov; 19(5):959-62. PubMed ID: 11604994
[TBL] [Abstract][Full Text] [Related]
4. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid.
Hoffman AD; Engelstein D; Bogenrieder T; Papandreou CN; Steckelman E; Dave A; Motzer RJ; Dmitrovsky E; Albino AP; Nanus DM
Clin Cancer Res; 1996 Jun; 2(6):1077-82. PubMed ID: 9816270
[TBL] [Abstract][Full Text] [Related]
5. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
[TBL] [Abstract][Full Text] [Related]
6. Synergistic anti-tumor effect of 13-cRA and IFN-alpha/beta in mouse renal cell carcinoma.
Taguchi I; Hara I; Gohji K; Arakawa S; Kamidono S
Int J Oncol; 1998 Jul; 13(1):145-9. PubMed ID: 9625816
[TBL] [Abstract][Full Text] [Related]
7. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
[TBL] [Abstract][Full Text] [Related]
9. High-level expression of the retinoic acid receptor beta gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells.
Geisen C; Denk C; Gremm B; Baust C; Karger A; Bollag W; Schwarz E
Cancer Res; 1997 Apr; 57(8):1460-7. PubMed ID: 9108446
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid receptor-beta prevents cisplatin-induced proximal tubular cell death.
Yago-Ibáñez J; García-Pastor C; Lucio-Cazaña FJ; Fernández-Martínez AB
Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165795. PubMed ID: 32278009
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a.
Berg WJ; Nanus DM; Leung A; Brown KT; Hutchinson B; Mazumdar M; Xu XC; Lotan R; Reuter VE; Motzer RJ
Clin Cancer Res; 1999 Jul; 5(7):1671-5. PubMed ID: 10430067
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of retinoic acid receptor alpha-mediated growth inhibition of gastric cancer cells by all-trans retinoic acid].
Wu Q; Chen Z; Liu S
Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):195-7. PubMed ID: 11778229
[TBL] [Abstract][Full Text] [Related]
13. CRABP I expression and the mediation of the sensitivity of human tumour cells to retinoic acid and irradiation.
Blaese MA; Santo-Hoeltje L; Rodemann HP
Int J Radiat Biol; 2003 Dec; 79(12):981-91. PubMed ID: 14713576
[TBL] [Abstract][Full Text] [Related]
14. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines.
Xu XC; Liu X; Tahara E; Lippman SM; Lotan R
Cancer Res; 1999 May; 59(10):2477-83. PubMed ID: 10344761
[TBL] [Abstract][Full Text] [Related]
15. Different ligand responsiveness of human retinoic-acid-receptor beta-gene transcription in tumorigenic and non-tumorigenic cervical-carcinoma-derived cell lines is mediated through a large retinoic-acid-response domain.
Baust C; Redpath L; Schwarz E
Int J Cancer; 1996 Jul; 67(3):409-16. PubMed ID: 8707417
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
17. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers.
Dunst J; Hänsgen G; Krause U; Füchsel G; Köhler U; Becker A
Strahlenther Onkol; 1998 Nov; 174(11):571-4. PubMed ID: 9830438
[TBL] [Abstract][Full Text] [Related]
18. Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies.
DiPaola RS; Rafi MM; Vyas V; Toppmeyer D; Rubin E; Patel J; Goodin S; Medina M; Medina P; Zamek R; Zhang C; White E; Gupta E; Hait WN
J Clin Oncol; 1999 Jul; 17(7):2213-8. PubMed ID: 10561278
[TBL] [Abstract][Full Text] [Related]
19. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells.
Li M; Song S; Lippman SM; Zhang XK; Liu X; Lotan R; Xu XC
Oncogene; 2002 Jan; 21(3):411-8. PubMed ID: 11821953
[TBL] [Abstract][Full Text] [Related]
20. The additive antiproliferative effect of all-trans retinoic acid and interferon-alpha2a on human cervical carcinoma cell lines is not associated with increased expression of retinoid receptors.
Wahlberg P; Einarsdottir M; Fex G; Rydell R
Anticancer Drugs; 1997 Jun; 8(5):522-8. PubMed ID: 9215617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]